The size of the structural heart imaging market was estimated at USD 14085.8 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.4% to reach USD 34912.46 million by 2030. (2023-2030).

Structural heart imaging (SHI) refers to a special technique to screen the heart at a molecular level. In cardiology practices, high-resolution cameras, and MRI with high tesla capacity are widely used to carry out structural heart imaging. It is an imaging technique that combines the use of light reflection to produce the image of the interior component, and generates a 2-dimensional cross-section interpretation. It facilitates accurate and clear diagnosis of the condition. The global structural heart imaging market is mainly driven by factors such as the growing prevalence of structural heart diseases (CHDs) globally, increasing developments in imaging modality technology along with rising awareness of heart-related diseases such as high blood pressure. According to an article published by the Centers for Disease Control and Prevention, in 2019, CHDs affect approx 1% of about 40,000 births per year and approximately 100-200 deaths occur due to unrecognized heart diseases in newborns each year in the United States. Therefore, as a result, demand for structural heart imaging is also rising, which further contributes to the growth of the global market. Besides, another major factor driving the market growth is accessibility and the increasing adoption of recent advanced devices. However, the main constraints for the structural heart imaging industry are high cost and limited reimbursement policies.

Increasing research and clinical trials related to structural heart imaging technique boosting the growth of the market

The growing application of angiograms in generalized imaging techniques often increases the likehood of adopting structural cardiac imaging techniques, consequently boosting demand for structural heart imaging. In addition, rising government funding in research and clinical trials for structural heart imaging techniques accelerate the market growth.

Echocardiogram segment is expected to account for significant revenue share in the global market

Echocardiogram segment is dominating the global market during the forecast period owing to the low cost associated with the test as compared to CT & MRI, growing number of valvular and nonvalvular heart disease, rapid demand in transcatheter aortic valve replacement along with its superiority in the visualization of intracardiac structures accelerate the growth of echocardiogram segment.

North America is expected to dominate the global market

Geographically, the global structural heart imaging market is classified into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Among these regions, North America is likely to hold the largest revenue share over the forecast period due to the availability of healthcare spending and advanced technology, and favorable reimbursement system.

Asia Pacific is projected to be the fastest-growing region in the forecast period owing to an increasing number of well-equipped and sophisticated hospitals and healthcare expenditure in a developing country like China and India. In addition, improvements in newborn screening programs further contribute to the growth of the market in this region.

Key Market Players

• Koninklijke Philips N.V.
• Siemens Healthineers GmbH
• Toshiba Corporation
• Circle Cardiovascular Imaging, Inc.
• CardioComm Solutions Inc.
• Pie Medical Imaging B.V.
• HeartSciences
• TomTec Imaging Systems GmbH
• 3mensio Medical Imaging BV
• Integer Holdings Corporation
• Shimadzu Corporation

structural heart imaging market Scope

Key Segment Of The structural heart imaging market

By Imaging Modality, (USD Million)            
    •    Echocardiogram
    •    Angiogram
By procedure type, (USD Million)
    •    Transcatheter Aortic Valve Replacement (TAVR) 
    •    Surgical Aortic Valve Replacement (SAVR) 
    •    Transcatheter Mitral Valve Repair (TMVR) 
    •    Left Atrial Appendage Closure (LAAC)
    •    Annuloplasty 
    •    Valvuloplasty
    •    Others
By Application (USD Million)
    •    Diagnosis
    •    Surgery
By End-user, (USD Million)
    •    Hospitals 
    •    Specialty Clinics 
    •    Cardiac Centers 
    •    Diagnostic Centers 
    •    Ambulatory Surgical Centers 
    •    Catheterization Laboratories 
    •    Others
Regional Overview, (USD Million)
    North America
      •    US
      •    Canada
    Europe
      •    Germany
      •    France
      •    UK
      •    Rest of Europe
    Asia Pacific
      •    China
      •    India
      •    Japan
      •    Rest of Asia Pacific
    South America
      •    Mexico
      •    Brazil
      •    Rest of South America
    Middle East and South Africa